Regarding “The cost will drop” (June 17, p. 12), it was a solid and sound decision. The Supreme Court correctly stated that Myriad did not invent anything, it discovered the genes.
I am a free-enterprise believer. However, this was a smudge on the patent process and not too far off from some Internet enterprises that want to sell stock just for their discovery of what people like. Discovering genes and other human parts that occur in a natural process produces revenue by using litigation threats based on exclusivity—not for doing something truly productive. Build something better, create and use the patent process as intended—not revenue by hostage with a false base of pricing. Use the genes to develop a process that no one else can do, or has done—and that process has more validity. I have no sympathy for the investors who did not do enough homework to see the flaw in the valuation process.
Dennis Gerber Physicians Health Advantage St. Augustine, Fla.